NME6 as a potential biomarker and therapeutic target involved in immune infiltration for lung adenocarcinoma

CONCLUSION: The analysis showed that NME6 is a crucial prognostic factor for LUAD patients. NME6 regulates genes related to m6A modification and immune cells infiltration. Furthermore, NME6 could sever as a potential therapeutic target for LUAD.PMID:38517815 | DOI:10.3233/THC-231058
Source: Technology and Health Care - Category: Medical Devices Authors: Source Type: research